(Reuters) – Bayer AG and Johnson & Johnson have agreed to settle more than 25,000 U.S. lawsuits over their blockbuster blood thinner Xarelto for a total of $775 million, court documents on Monday showed.
Bayer, J&J settle U.S. Xarelto litigation for $775 million
Website developed in accordance with Web Content Accessibility Guidelines 2.1.
If you encounter any issues while using this site, please contact us: 516.579.6500
If you encounter any issues while using this site, please contact us: 516.579.6500
